1p36.22 region containing PGD gene is frequently gained in human cervical cancer

Abstract

AimTo identify commonly occurring DNA copy number alterations in Korean cervical cancers. MethodsDNA copy number alteration was screened by whole-genome array comparative genomic hybridization (CGH) analysis. For the array CGH discovery, genomic DNA from five cervical cancers and 10 normal cervical tissues were examined. For the independent validation of the most significant chromosomal alteration (1p36.22, PGD gene), 40 formalin-fixed paraffin-embedded cervical tissue samples were collected; 10 of them were used for quantitative polymerase chain reaction and the other 30 samples were used for immunohistochemical analysis. Chromosomal segments differently distributed between cancers and normal controls were determined to be recurrently altered regions (RAR). ResultsA total of 13 RAR (11 RAR losses and two RAR gains) were defined in this study. Of the 13 cervical cancer-specific RAR, RAR gain in the 1p36.22 locus where the PGD gene is located was the most commonly detected in cancers (P=0.004). In the quantitative polymerase chain reaction replication, copy number gain of the PGD gene was consistently identified in cervical cancers but not in the normal tissues (P=0.02). In immunohistochemical analysis, PGD expression was significantly higher in cervical cancers than normal tissues (P=0.02). ConclusionOur results will be helpful to understand cervical carcinogenesis, and the PGD gene can be a useful biomarker of cervical cancer.